226 related articles for article (PubMed ID: 28622182)
21. Pancreaticobiliary maljunction: pathophysiological and clinical aspects and the impact on biliary carcinogenesis.
Matsumoto Y; Fujii H; Itakura J; Matsuda M; Yang Y; Nobukawa B; Suda K
Langenbecks Arch Surg; 2003 Apr; 388(2):122-31. PubMed ID: 12684801
[TBL] [Abstract][Full Text] [Related]
22. Frequent expression of mucin core protein MUC1 in non-neoplastic gallbladder mucosa from patients with pancreaticobiliary maljunction.
Yamato T; Kurumaya H; Ohama K; Yamamichi N; Watanabe Y; Harada K; Sasaki M; Nakanuma Y
Liver; 1999 Aug; 19(4):281-7. PubMed ID: 10459625
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic usefulness of SpyGlass in intracholecystic papillary neoplasm with pancreaticobiliary maljunction: a case report and comparison with conventional gallbladder cancer with pancreaticobiliary maljunction.
Akita M; Yanagimoto H; Tsugawa D; Ajiki T; Masuda A; Komatsu M; Goto T; Kido M; Toyama H; Fukumoto T
Clin J Gastroenterol; 2023 Jun; 16(3):476-481. PubMed ID: 36867354
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in pancreaticobiliary maljunction.
Matsumoto Y; Fujii H; Itakura J; Matsuda M; Nobukawa B; Suda K
J Hepatobiliary Pancreat Surg; 2002; 9(1):45-54. PubMed ID: 12021897
[TBL] [Abstract][Full Text] [Related]
25. Pancreas divisum in pancreaticobiliary maljunction.
Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A; Matsukawa M
Hepatogastroenterology; 2008; 55(81):249-53. PubMed ID: 18507118
[TBL] [Abstract][Full Text] [Related]
26. Risk factor for extrahepatic bile duct cancer in patients with anomalous pancreaticobiliary ductal union.
Jung YS; Lee KJ; Kim H; Kim WH; Kim IG; Yoo BM; Kim JH; Kim MW
Hepatogastroenterology; 2004; 51(58):946-9. PubMed ID: 15239220
[TBL] [Abstract][Full Text] [Related]
27. Carcinogenesis and chemoprevention of biliary tract cancer in pancreaticobiliary maljunction.
Tsuchida A; Itoi T
World J Gastrointest Oncol; 2010 Mar; 2(3):130-5. PubMed ID: 21160820
[TBL] [Abstract][Full Text] [Related]
28. Carcinoma of the gallbladder with an anomalous connection between the choledochus and the pancreatic duct. Report of 10 cases and review of the literature in Japan.
Kinoshita H; Nagata E; Hirohashi K; Sakai K; Kobayashi Y
Cancer; 1984 Aug; 54(4):762-9. PubMed ID: 6744208
[TBL] [Abstract][Full Text] [Related]
29. Prophylactic excision of the gallbladder and bile duct for patients with pancreaticobiliary maljunction.
Kobayashi S; Asano T; Yamasaki M; Kenmochi T; Saigo K; Ochiai T
Arch Surg; 2001 Jul; 136(7):759-63. PubMed ID: 11448385
[TBL] [Abstract][Full Text] [Related]
30. Recent advances and problems in the management of pancreaticobiliary maljunction: feedback from the guidelines committee.
Kamisawa T; Ando H; Shimada M; Hamada Y; Itoi T; Takayashiki T; Miyazaki M
J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):87-92. PubMed ID: 23798483
[TBL] [Abstract][Full Text] [Related]
31. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction.
Masuhara S; Kasuya K; Aoki T; Yoshimatsu A; Tsuchida A; Koyanagi Y
J Hepatobiliary Pancreat Surg; 2000; 7(2):198-205. PubMed ID: 10982614
[TBL] [Abstract][Full Text] [Related]
32. IL-33 overexpression in gallbladder cancers associated with pancreatobiliary maljunction.
Tomioka Y; Sung YN; Sawada R; Hong SM; Akita M; Itoh T; Ajiki T; Fukumoto T; Zen Y
Histopathology; 2019 Sep; 75(3):365-375. PubMed ID: 30882917
[TBL] [Abstract][Full Text] [Related]
33. Thickened inner hypoechoic layer of the gallbladder wall in the diagnosis of anomalous pancreaticobiliary ductal union with endosonography.
Tanno S; Obara T; Maguchi H; Mizukami Y; Shudo R; Fujii T; Takahashi K; Nishino N; Arisato S; Saitoh Y; Ura H; Kohgo Y
Gastrointest Endosc; 1997 Dec; 46(6):520-6. PubMed ID: 9434219
[TBL] [Abstract][Full Text] [Related]
34. Hilar cholangiocarcinoma accompanied by pancreaticobiliary maljunction without bile duct dilatation 20 years after cholecystectomy: report of a case.
Yamada S; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Mori H; Kanamoto M; Hanaoka J; Iwahashi S; Saito Y; Ishibashi H
J Med Invest; 2013; 60(1-2):169-73. PubMed ID: 23614928
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis and treatment of pancreaticobiliary maljunction in children.
Ono S; Fumino S; Iwai N
Surg Today; 2011 May; 41(5):601-5. PubMed ID: 21533929
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic diagnosis of pancreaticobiliary maljunction.
Kamisawa T; Takuma K; Itokawa F; Itoi T
World J Gastrointest Endosc; 2011 Jan; 3(1):1-5. PubMed ID: 21258599
[TBL] [Abstract][Full Text] [Related]
37. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Nagai M; Watanabe M; Iwase T; Yamao K; Isaji S
World J Surg; 2002 Jan; 26(1):91-8. PubMed ID: 11898040
[TBL] [Abstract][Full Text] [Related]
38. Telomere length of gallbladder epithelium is shortened in patients with congenital biliary dilatation: measurement by quantitative fluorescence in situ hybridization.
Aoki Y; Aida J; Kawano Y; Nakamura KI; Izumiyama-Shimomura N; Ishikawa N; Arai T; Nakamura Y; Taniai N; Uchida E; Takubo K; Ishiwata T
J Gastroenterol; 2018 Feb; 53(2):291-301. PubMed ID: 29143121
[TBL] [Abstract][Full Text] [Related]
39. Mucosal cell proliferation activity of the gallbladder in children with anomalous arrangement of the pancreaticobiliary duct.
Tokiwa K; Ono S; Iwai N
J Hepatobiliary Pancreat Surg; 1999; 6(3):213-7. PubMed ID: 10526054
[TBL] [Abstract][Full Text] [Related]
40. Preferable operative age of choledochal dilation types to prevent patients with pancreaticobiliary maljunction from developing biliary tract carcinogenesis.
Kobayashi S; Ohnuma N; Yoshida H; Ohtsuka Y; Terui K; Asano T; Ryu M; Ochiai T
Surgery; 2006 Jan; 139(1):33-8. PubMed ID: 16364715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
